Why Merrill Lynch Downgraded Private Equity Giants
Looking at 2015, it has not been the most monumental year for a few industries, in particular private equity companies.
All Work
Chris Lange
How Analysts View Instructure After the Quiet Period
Now that the quiet period is over for Instructure, we can get a better view of what to expect from the company as its underwriters support its valuation and give an outlook as to…
What to Look For in Lululemon Earnings
Lululemon Athletica is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday.
What to Look for in Costco Earnings
Costco Wholesaleis scheduled to report its fiscal first-quarter financial results after the markets close on Tuesday.
Why TherapeuticsMD Is Skyrocketing
TherapeuticsMDwas leading the health care sector in Tuesday’s session on positive top-line results from one of its late-stage trials.
Why Onconova Is Soaring
Onconova Therapeutics led the bulls early in Tuesday’s trading session on positive data from an ongoing Phase 1/2 clinical trial.
AutoZone Expansion Rings Up Earnings Beat
AutoZone reported mixed fiscal first-quarter financial results before the markets opened on Tuesday.
Conns Sinks on Earnings Miss
Conns reported disappointing fiscal third-quarter financial results before the markets opened on Tuesday.
H&R Block Loss Precipitates Sliding Shares
H&R Block reported disappointing fiscal second-quarter financial results after the markets closed on Monday.
Jefferies Top Pharma Stock Picks for 2016
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
SEC Charges Lawyers Acting as Unregistered Brokers
The SEC announced a series of enforcement actions against lawyers across the United States charged with offering EB-5 investments while not registered to act as brokers.
Why Key Analyst Still Sees Some Upside in Bluebird Bio
Bluebird Bio absolutely tanked in Monday's trading session, based on preclinical and manufacturing data from the American Society of Hematology Annual Meeting.
Why Threshold Pharma Is Imploding
Threshold Pharmaceuticals watched its stock completely collapse in Monday’s session after a joint late-stage study failed to yield positive results.
Idera Pharma Soars Over Positive Trial Data
Idera Pharmaceuticals made a strong push in Monday’s session following the presentation of its clinical data over the weekend.
MEI Pharma Bounces Off Lows After Positive Phase 2 Results
MEI Pharma Inc. (NASDAQ: MEIP) was leading the bulls in the broad markets Monday on news of positive Phase 2 results. The company announced positive results from a study of its investigational drug candidate…
Mattress Firm Earnings Not Enough for Investors
Mattress Firm released better-than-expected fiscal third-quarter earnings report before the markets opened on Monday.
Vail Resorts Wows Investors Despite Loss
Vail Resorts reported better-than-expected fiscal first-quarter financial results before the markets opened on Monday.
Does Chipotle Have Even More Downside Than Previously Thought?
Chipotle Mexican Grill issued updated guidance on where it stands with its E. coli outbreak, and things look much worse than previously thought.
Are Keurig Shareholders Getting Enough?
Keurig Green Mountain is going private in a deal worth approximately $14 billion, but are shareholders getting enough?
Top 7 Earnings Previews for the Week Ahead
24/7 Wall St. has put together a preview of Marvell Technology, Lululemon Athletica and other major companies reporting their quarterly results this week.